Abstract |
The most common causes of hypercalcemia are primary hyperparathyroidism (PHPT) and malignancy. Parathyroid carcinoma (PC), causing a severe PHPT, is the rarest parathyroid tumor. A diagnosis of PC is challenging because the clinical profile overlaps with that of benign counterpart. Surgery is the mainstay treatment. CDC73 mutations have been detected in up to 80% of sporadic PCs. Ectopic production of parathyroid hormone (PTH) by malignant nonparathyroid tumors is a rare condition accounting for less than 1% of hypercalcemia of malignancy. PTH secretion can be considered an aberration in the tissue specificity of gene expression and may involve heterogeneous molecular mechanisms.
|
Authors | Filomena Cetani, Elena Pardi, Claudio Marcocci |
Journal | Endocrinology and metabolism clinics of North America
(Endocrinol Metab Clin North Am)
Vol. 50
Issue 4
Pg. 683-709
(12 2021)
ISSN: 1558-4410 [Electronic] United States |
PMID | 34774241
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Copyright | Copyright © 2021 Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Humans
- Hypercalcemia
(etiology)
- Parathyroid Hormone
- Parathyroid Neoplasms
(complications, diagnosis, genetics)
|